All Stories

  1. Proton Pump Inhibitors and Kidney Disease: What Gives?
  2. Hiding in plain sight: Catastrophic diethylene glycol poisonings in children
  3. Drug-Induced Acute Kidney Injury
  4. Adverse Drug Effects in Patients with CKD
  5. Acute kidney injury in a patient with lymphoma
  6. Images in Onco-Nephrology: Welcome to a new feature in the Journal of Onco-Nephrology
  7. Atypical urinary crystals in a patient with acute kidney injury
  8. The nephrotoxicity of new immunotherapies
  9. AKI in Patients Receiving Immune Checkpoint Inhibitors
  10. Evolution of the kidney–cancer connection
  11. Treatment of Drug-Induced Acute Tubulointerstitial Nephritis
  12. Nephrotoxicity of Cancer Immunotherapies: Past, Present and Future
  13. The adverse kidney effects of cancer immunotherapies
  14. Pharmacology behind Common Drug Nephrotoxicities
  15. Severe Orthostatic Hypotension Complicating Multiple Myeloma
  16. AKI in Multiple Myeloma: Paraproteins, Metabolic Disturbances, and Drug Toxicity
  17. New Horizons in Nephrology: Update in Onco-Nephrology
  18. Drug-Induced Acute Interstitial Nephritis
  19. Growth of the Kidney–Cancer Connection
  20. Update on the Renal Effects of Anticancer Agents
  21. Renal Consults from the Oncology Floor
  22. Crizotinib: Renal Safety Evaluation
  23. Paraprotein-Related Kidney Disease: Attack of the Killer M Proteins
  24. Commentary
  25. Nephrologists as teachers, role of educational scholarship
  26. Drug-Induced Glomerular Disease: Attention Required!
  27. Drug-Induced Glomerular Disease: Direct Cellular Injury
  28. Urinary Biomarkers and Progression of AKI in Patients with Cirrhosis
  29. Urinary Eosinophils in AIN: Farewell to an Old Biomarker?
  30. Dabigatran and Kidney Disease: A Bad Combination
  31. AKI in a Hospitalized Patient with Cellulitis
  32. Onco-Nephrology: Renal Toxicities of Chemotherapeutic Agents
  33. Traditional Urinary Biomarkers in the Assessment of Hospital-Acquired AKI